VIENNA/WASHINGTON -- Facing pressure amid renewed surges in coronavirus cases in India and other emerging countries, the U.S. has begun considering loosening vaccine patent protections to increase global access to the shots.
COVID vaccines
India COVID crisis raises pressure on US to waive vaccine patents
Emerging countries push for a WTO-rule exemption amid surging infections
